DGM Fresher's job

• Lead the team of Chemical Engineers/ Chemists at sites for Tech absorption & Transfer
• Perform Process Scale up studies in Lab/ CPP to establish a robust process for trial and validations for tech transfer & scale-up activity..
• Recommend the right equipment for scale up and provide support in the execution of scale up batches at CPP.
• Map the equipment’s based on the volume calculations from Kilo lab and lab data.
• Prepare the BPR, BOM & recipe and ensure their approval for batch start up.
• Ensuring the facility readiness with respect to cleanliness, temperature blank trials, equipment occupancy etc.
• Support in performing Facility and Process Safety Analysis by conducting PHA & PSI, which includes What-If, HAZOP studies by coordinating with all CFT’s.
• Preparation/ review of MFD, PFD, P&ID’s, BPR and Utility calculation in coordination with CFT’s.

• Providing Technical support during Incident Investigation of batch failures in order to find out and eliminate root causes.
• Involving in new process equipment procurement by preparing/review URS, Project costing and basic PFD and providing support during equipment installation & qualification.
• Providing training to the production personnel before starting the new processes at CPP. This training includes Safety, Quality, Critical parameters, Process and Product Information.
• Should have sufficient exposure on physical characteristic evaluation of APIs, including PSD, surface area etc.

Apply Link- Apply Link mentioned in below

Sun Pharma is the No. 1 and largest pharmaceutical company in India with over 8% market share in the domestic market (AIOCD AWACS for 12 months ending June 2022). The company has been ranked No. 1 with over 11 different classes of doctors (SMSRC Prescription Data). Sun Pharmas branded generics business in India commands leading position in high-growth chronic therapies and strong positioning in the acute segment.
Sun Pharma India specializes in technically complex products, offering a comprehensive therapy basket, and owns 33 brands out of the top 300 pharmaceutical brands in India. The top 10 brands contribute about 18% of India revenues. The top therapeuticsegments which contribute significantly to the companys revenue and market share are Neuro-Psychiatry (16%), Gastroenterelogy (13%), Anti-Infectives (10%), Diabetology (8%), and; Pain/Analgesics (7%) among others. The companys growth is driven by a basket of brands and low product concentration. With over 10,000 strong sales force reaching around 600,000 doctors, the company has one of widest reaches to Indias medical fraternity for therapy focused marketing.